Диссертация (1141028), страница 16
Текст из файла (страница 16)
Структура и иерархия таксономических групп микробиотыкожи больных УБ в Приморском крае/ С.Н.Рахманова, В.А.Шаркова, А.Д.Юцковский // Тихоокеанский медицинский журнал. - 2011. - N3. - С. 34-36.23.Самцов, А.В. Топические антибиотики в лечении акне / А.В.Самцов //Вестник дерматологии и венерологии. – 2011. - N1. – C.84-85.24.Свирщевская, Е.В. Комбинированные топические ретиноиды в терапииакне/ Свирщевская Е.В., Матушевская Е.В.// Дерматология. - 2011.- N3.- С.4-6.25.Сергеев, В.Ю.
Видеодерматоскопия: новое в повседневной врачебнойпрактике дерматовенеролога/ Сергеев Ю.В., Иванов О.Л. // Российский журналкожных и венерических болезней. – 2009. - N4 – C.15-20.26.Соколов,Д.В.эпилюминисцентнойИсториямикроскопииразвитияметода(дерматоскопии)кожи/поверхностнойД.В.Соколов,Л.В.Демидов, Т.С.Белышева, Н.Н. Потекаев // Клиническая дерматология ивенерологоия. - 2009. - N1 - С.11-14.27.Федеральныеклиническиерекомендации.Дерматовенерология2015:Болезни кожи. Инфекции, передаваемые половым путем.
– М.: Деловойэкспресс, 2016.- 768с.28.Юцковская, Я.А. Эстетические аспекты комбинированной гормональнойтерапии с антиандрогенными прогестагенами в различные периоды жизниженщин / Я.А Юцковская, С.В. Юренева // Пластическая хирургия икосметология. – 2011.- N3.- С.385-576.29.Ahn, CS. Adherence in dermatology / CS Ahn, L Culp, WW Huang, SR. Feldman// J Dermatolog Treat. – 2016.- N15. – P.1-10.30.Alirezaï, M. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatmentof acne vulgaris / M. Alirezaï, B.
Gerlach, A. Horvath, D. Forsea et all// Eur JDermatol. – 2005.- V.15. - N.4.- P.274-8.10131.Anderson, K.L. Frequency of Primary Nonadherence to Acne Treatment / K.L.Anderson, E.H. Dothard, K.E. Huang, S.R. Feldman// JAMA Dermatol. - 2015V.151.- N.6- P.623-6.32.Austin, B.A. The extinction of topical erythromycin therapy for acne vulgarisand concern for the future of topical clindamycin / B.A.Austin, A.B.
Jr. Fleischer //J Dermatolog Treat. – 2016.- N.2.- P.1-4.33.Bollenbach T. Antimicrobial interactions: mechanisms and implications for drugdiscovery and resistance evolution / T. Bollenbach // Curr Opin Microbiol. – 2015.N.27.- P.1-9.34.Benvenuto-Andrade, C. Differences between polarized light dermoscopy andimmersion contact dermoscopy for the evaluation of skin lesions / C. BenvenutoAndrade, S.W. Dusza, A.L.Agero, A.Scope et al.
// Arch Dermatol. – 2007.V.143.- N.3.- P.329-38.35.Bez, Y. High social phobia frequency and related disability in patients with acnevulgaris/ Y. Bez, Y. Yesilova, M.C. Kaya, A. Sir// Eur J Dermatol. – 2011.-V.21.N.5.- P.756-60.36.Bhate, K. Epidemiology of acne vulgaris/ K.Bhate, H.C.Williams // B JDermatology. – 2013. – N.168. – P.474-485.37.Bhavsar, B. Clindamycin 1% Nano-emulsion Gel Formulation for the Treatmentof Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, PhaseIV Clinical Trial / B. Bhavsar, B.
Choksi, J. Sanmukhani, A. Dogra // J Clin DiagnRes. – 2014. – V.8. – N.8. – P.YC05-9.38.Bikowski, J. A new approach to comparing efficacy results from clinical trials oftopical acne vulgaris treatments/ J. Bikowski // J Drugs Dermatol. – 2007.- V.6. –N.7. – P.688-92.39.Campbell, JL. A comparative review of the efficacy and tolerability of retinoid-containing combination regimens for the treatment of acne vulgaris / J.L.Campbell// JDrugs Dermatol. – 2007.- V.6.- N.6. – P.625-629.40.Chiang, A. Skin lesion metrics: role of photography in acne / A.Chiang, F.Hafeez, H.I.Maibach // J Dermatolog Treat. – 2014.- V.25.
– N.2. – P.100-5.10241.Christiansen, JV. Topical tretinoin, vitamin A acid (Airol) in acne vulgaris. Acontrolled clinical trial / J.V. Christiansen, E. Gadborg, K. Ludvigsen, C.H. Meier etal.// Dermatologica. – 1974. – V.148. – N.2. – P.82-9.42.Coenye, T. In vitro and in vivo model systems to study microbial biofilmformation / T. Coenye, H.J. Nelis // J Microbiol Methods.
– 2010.- V.83.- P.2. – P.89105.43.Cunliffe, W.J. Clinical efficacy and safety comparison of adapalene gel andtretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials/W.J. Cunliffe, R. Caputo, B. Dreno, L. Förström // J Am Acad Dermatol. – 1997.V.36. – N.6.-Pt.2.- P.S126-34.44.Delost, G.R. Staphylococcus aureus carriage rates and antibiotic resistancepatterns in patients with acne vulgaris / G.R.
Delost, M.E. Delost, J. Armile, J. Lloyd// J Am Acad Dermatol. – 2016.- N.14.-P.S0190-9622(15)02497-4.45.Del Rosso, J.Q. Topical and oral antibiotics for acne vulgaris / J.Q. Del Rosso//Semin Cutan Med Surg. – 2016. – V.35. – N.2). – P.57-61.46.Del Rosso JQ. Status Report from the Scientific Panel on Antibiotic Use inDermatology of the American Acne and Rosacea Society: Part 3: CurrentPerspectives on Skin and Soft Tissue Infections with Emphasis on Methicillinresistant Staphylococcus aureus, Commonly Encountered Scenarios when AntibioticUse May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics inDermatology / JQ Del Rosso, T. Rosen, D. Thiboutot, GF Webster et all. // J ClinAesthet Dermatol. – 2016.
– V.9. - №6. – P.17-24.47.Diep, B.A. Complete genome sequence of USA300, an epidemic clone ofcommunity-acquired meticillin-resistant Staphylococcus aureus / B.A. Diep, S.R.Gill, R.F. Chang, T.H. Phan// Lancet. – 2006. – V.4. – N.367(9512). – P.731-9.48.Dreno, B. Assessing Quality of Life in Patients with Acne Vulgaris: Implicationsfor Treatment / B. Dreno// Am J Clin Dermatol. – 2006.
– V.7. – N.2. – P.99—106.49.Dreno, B. Global Alliance to Improve Outcomes in Acne. Antibiotic stewardshipin dermatology: limiting antibiotic use in acne/ B. Dreno, D. Thiboutot, H. Gollnicket al.// Eur J Dermatol. – 2014.- V.24. – N.3. – P.330-4.10350.Dréno, B. Microbiome in healthy skin, update for dermatologists/ B.
Dréno, E.Araviiskaia, E. Berardesca, G. Gontijo et al.// J Eur Acad Dermatol Venereol. –2016.- V.30.- N.12. – P.2038-2047.51.Fanelli, M. Antibiotics, acne, and Staphylococcus aureus colonization / M.Fanelli, E. Kupperman, E. Lautenbach, P.H. Edelstein, D.J.Margolis et al. //ArchDermatol. – 2011.- V.147. – N.8. –P.917-21.52.Fehnel, S.E. Responsiveness of the Acne-Specific Quality of Life Questionnaire(Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials/ S.E.Fehnel, L.D.
McLeod, J.Brandman, D.I.Arbit et al.// Qual Life Res. – 2002.- V.11.N.8. – P.809-16.53.Finlay, A.Y. Dermatology Life Quality Index (DLQI)--a simple practical measurefor routine clinical use/ A.Y. Finlay, G.K. Khan// Clin Exp Dermatol.
– 1994.- V.19. –N.3. – P.210-6.54.Fournier, B. The function of TLR2 during staphylococcal diseases/ B.Fournier//Front Cell Infect Microbiol. – 2013.- V.4. – N.2. – P.167.55.Fritz, S.A. Staphylococcus aureus colonization in children with community-associated Staphylococcus aureus skin infections and their household contacts / S.A.Fritz, P.G. Hogan, G. Hayek, K.A.
Eisenstein et al. // Arch Pediatr Adolesc Med. –2012. – V.166. – N.6. – P.551-7.56.Galvin, S.A. Comparative tolerance of adapalene 0.1% gel and six differenttretinoin formulations / S.A. Galvin, R.Gilbert, M. Baker, F.Guibal et al.// Br JDermatol.
– 1998. – N.139. - Suppl 52. – P.34-40.57.Gollnick, H. Management of acne: a report from a Global Alliance to ImproveOutcomes in Acne / H. Gollnick, W.Cunliffe, D. Berson, B. Dreno et al.// J Am AcadDermatol. – 2003. – V.49. – Suppl.1. – P. S1-37.58.del Giudice, P. Long-term use of tetracycline and Staphylococcus aureustetracycline resistance: not only a problem of acne / P. del Giudice, T.
Hubiche, J.Etienne // Arch Dermatol. 2012 Mar; 148(3):402.10459.Hassanzadeh, P. Bacterial resistance to antibiotics in acne vulgaris: an in vitrostudy / P. Hassanzadeh, M. Bahmani, D. Mehrabani // Indian J Dermatol. – 2008.V.53. – N.3.- P.122-4.60.Hayashi, N. Acne Study Group.Establishment of grading criteria for acneseverity/ N. Hayashi, H.
Akamatsu, M. Kawashima// J Dermatol. – 2008.- V.35. N.5. – P.255-60.61.Huang, K.E. The duration of acne treatment / K.E. Huang, S.E. Carstensen, S.R.Feldman // J Drugs Dermatol. – 2014.- V.13. – N.6. – P.655-6.62.Iinuma, K. Involvement of Propionibacterium acnes in the augmentation oflipogenesis in hamster sebaceous glands in vivo and in vitro/ K. Iinuma, T. Sato, N.Akimoto, N. Noguchi et al.// J Invest Dermatol.
– 2009. – V.129. – N.9. – P.2113-9.63.Jahns, A.C. An increased incidence of Propionibacterium acnes biofilms in acnevulgaris: a case-control study/ A.C. Jahns, B. Lundskog,R. Ganceviciene et al.// Br JDermatol. – 2012. – N.167. – P.50-58.64.Jahns, A.C. Spatial distribution of bacterial-fungal communities in facial skin /A.C. Jahns, I. Golovleva, R.H. Palmer, O.A.
Alexeyev// J Dermatol Sci. – 2013.V.70. – N.1. – P.71-3.65.Kakita, L. Tazarotene versus tretinoin or adapalene in the treatment of acnevulgaris / L. Kakita// J Am Acad Dermatol. – 2000. – V.43. – N.2. – Pt 3. P.S51-4.66.Kong, H.H. Skin microbiome: genomics-based insights into the diversity and roleof skin microbes/ H.H. Kong // Trends Mol Med.
– 2011. – V.17.- N.6. – P.320-8.67.Kubota, Y. Effect of sequential application of topical adapalene and clindamycinphosphate in the treatment of Japanese patients with acne vulgaris/ Y. Kubota, A.Munehiro, Y. Shirahige, K. Nakai et al.// J Dermatolog Treat. – 2012. – V.23.
– N.1.– P.37-45.68.Kumar, S. Biochemistry of bacterial multidrug efflux pumps / S. Kumar, M.F.Varela // Int J Mol Sci. – 2012/ - V.13. – N.4. – P.4484-95.69.Leeming, J.P. The microbial colonization of inflamed acne vulgaris lesions / J.P.Leeming, K.T. Holland, W.J.Cuncliffe // Br J Dermatol. 1988 Feb;118(2):203-8.10570.Leyden, JJ.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
